【《医学世界报导》1989年7月】根据荷兰研究工作者在美国俄亥俄州辛辛那提市举行的美国风湿病学学会的会议上报告,柳氮磺胺吡啶如与羟氯喹比较,从 X 线检查的结果来看,能明显减慢类风湿性关节炎病变的进展。荷兰的 Dcsiree Van der Heijde 在会议上报告称,把60例类风湿性关节炎病人随机分为两组,每组30例,经过48周治疗后,柳氮磺胺吡啶组病人的手足关节,平均只有5个侵蚀损害,而在羟氯喹组则有16个侵蚀损害:在经过24周治疗,X 线检查已显示两组有 Medical World Report, July 1989 According to a report by a Dutch investigator at the American College of Rheumatology meeting in Cincinnati, Ohio, USA, sulfasalazine, as compared with hydroxychloroquine, From the point of view, can significantly slow down the progress of rheumatoid arthritis. Dcsiree Van der Heijde of the Netherlands reported at the meeting that 60 patients with rheumatoid arthritis were randomized into two groups of 30 patients. After 48 weeks of treatment, the patients in the sulfasalazine group had on average only 5 erosion lesions compared with 16 erosion lesions in the hydroxychloroquine group: after 24 weeks of treatment, X-rays showed that both groups had